Ultragenyx Pharmaceutical reported $846.88M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Aptinyx Inc APTX:US $ 132.41M 1.37M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Epizyme EPZM:US $ 247.6M 24.89M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Insmed INSM:US $ 958.98M 79.21M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Kyowa Hakko Kirin 4151:JP Y 494109M 41400M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Vital Therapies VTL:US $ 122.5M 20.81M
Xoma XOMA:US $ 74.87M 12.38M